1
|
Lefebvre T, Campas M, Matta K, Ouzia S, Guitton Y, Duval G, Ploteau S, Marchand P, Le Bizec B, Freour T, Antignac JP, de Tullio P, Cano-Sancho G. A comprehensive multiplatform metabolomic analysis reveals alterations of 2-hydroxybutyric acid among women with deep endometriosis related to the pesticide trans-nonachlor. THE SCIENCE OF THE TOTAL ENVIRONMENT 2024; 918:170678. [PMID: 38316313 DOI: 10.1016/j.scitotenv.2024.170678] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/12/2023] [Revised: 01/30/2024] [Accepted: 02/02/2024] [Indexed: 02/07/2024]
Abstract
BACKGROUND Exposure to persistent organic pollutants (POPs) has been related to the risk of endometriosis however the mechanisms remain unclear. The objective of the present study was to characterize the metabolic profiles underpinning the associations between POPs and endometriosis risk. METHODOLOGY A hospital-based case-control study was conducted in France to recruit women with and without surgically confirmed deep endometriosis. Women's serum was analyzed using gas and liquid chromatography coupled to high-resolution mass spectrometry (HRMS) to measure the levels of polychlorinated biphenyls (PCBs), organochlorinated pesticides (OCPs) and per-/polyfluoroalkyl substances (PFAS). A comprehensive metabolomic profiling was conducted using targeted HRMS and 1H nuclear magnetic resonance (1H NMR) to cover polar and non-polar fractions. A "meet-in-the-middle" statistical framework was applied to identify the metabolites related to endometriosis and POP levels, using multivariate linear and logistic regressions adjusting for confounding variables. RESULTS Fourteen PCBs, six OCPs and six PFAS were widely found in almost all serum samples. The pesticide trans-nonachlor was the POP most strongly and positively associated with deep endometriosis risk, with odds ratio (95 % confidence interval) of 2.42 (1.49; 4.12), followed by PCB180 and 167. Women with endometriosis exhibited a distinctive metabolic profile, with elevated serum levels of lactate, ketone bodies and multiple amino acids and lower levels of bile acids, phosphatidylcholines (PCs), cortisol and hippuric acid. The metabolite 2-hydroxybutyrate was simultaneously associated to endometriosis risk and exposure to trans-nonachlor. CONCLUSIONS To the best of our knowledge, this is the first comprehensive metabolome-wide association study of endometriosis, integrating ultra-trace profiling of POPs. The results confirmed a metabolic alteration among women with deep endometriosis that could be also associated to the exposure to POPs. Further observational and experimental studies will be required to delineate the causal ordering of those associations and gain insight on the underlying mechanisms.
Collapse
Affiliation(s)
- Tiphaine Lefebvre
- Oniris, INRAE, LABERCA, Nantes, France; CHU Nantes, Nantes Université, Service de Médecine et Biologie de la Reproduction, Gynécologie médicale, 38 bd Jean Monnet, Nantes, France; Faculty of Medicine, Nantes Université, France; Department of Gynecology and Obstetrics, Centre Hospitalier Départemental Vendée, 85000 la Roche sur Yon, France
| | - Manon Campas
- Centre for Interdisciplinary Research on Medicines (CIRM), Metabolomics Group, University of Liège, Belgium
| | | | - Sadia Ouzia
- Oniris, INRAE, LABERCA, Nantes, France; MetaboHUB-MELISA, MetaboHUB-ANR-11-INBS-0010, Oniris, INRAE, LABERCA, Nantes, France
| | - Yann Guitton
- Oniris, INRAE, LABERCA, Nantes, France; MetaboHUB-MELISA, MetaboHUB-ANR-11-INBS-0010, Oniris, INRAE, LABERCA, Nantes, France
| | - Gauthier Duval
- Oniris, INRAE, LABERCA, Nantes, France; CHU Nantes, Nantes Université, Service de Médecine et Biologie de la Reproduction, Gynécologie médicale, 38 bd Jean Monnet, Nantes, France
| | - Stéphane Ploteau
- CHU Nantes, Nantes Université, Service de Médecine et Biologie de la Reproduction, Gynécologie médicale, 38 bd Jean Monnet, Nantes, France; CHU Nantes, Department of Gynecology and Obstetrics, 38 bd Jean Monnet, Nantes, France
| | | | | | - Thomas Freour
- CHU Nantes, Nantes Université, Service de Médecine et Biologie de la Reproduction, Gynécologie médicale, 38 bd Jean Monnet, Nantes, France; Department of Reproductive Medicine, Dexeus University Hospital, Barcelona, Spain
| | | | - Pascal de Tullio
- MetaboHUB-MELISA, MetaboHUB-ANR-11-INBS-0010, Oniris, INRAE, LABERCA, Nantes, France
| | | |
Collapse
|
2
|
Lin Y, Zhang Y, Wang S, Yang Q. Elucidating the relationship between metabolites and breast cancer: A Mendelian randomization study. Toxicol Appl Pharmacol 2024; 484:116855. [PMID: 38341104 DOI: 10.1016/j.taap.2024.116855] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2023] [Revised: 01/27/2024] [Accepted: 02/06/2024] [Indexed: 02/12/2024]
Abstract
The evidence about the causal roles of metabolites in breast cancer is lacking. This study conducted a systematic evaluation of the potential causal relationship between 1091 human blood metabolites, 309 metabolite ratios, and the likelihood of developing breast cancer and its subtype by employing a two-sample bidirectional Mendelian randomization (MR) approach Four metabolites, including tryptophan betaine (Odds Ratio [OR] = 1.07, 95%CI = 1.04-1.10, Bonferroni-corrected P = 0.007), X-21312 (OR = 0.90, 95%CI = 0.86-0.94, Bonferroni-corrected P = 0.02), 3-bromo-5-chloro-2,6-dihydroxybenzoic acid (OR = 0.94, 95%CI = 0.91-0.96, Bonferroni-corrected P = 0.03) and X-18921 (OR = 0.96, 95%CI = 0.94-0.98, Bonferroni-corrected P = 0.04) were significantly associated with overall breast cancer using inverse-variance weighted (IVW) method. Tryptophan betaine was also significantly associated with estrogen receptor (ER)-positive breast cancer (OR = 1.08, 95%CI = 1.04-1.11, Bonferroni-corrected P = 0.03). X-23680 (OR = 1.10, 95%CI = 1.05-1.15, Bonferroni-corrected P = 0.04) and glycine to phosphate ratio (OR = 1.07, 95%CI = 1.04-1.10, Bonferroni-corrected P = 0.04) were associated with ER-negative breast cancer. Reverse MR analysis showed no significant associations between breast cancer and metabolites. This MR study indicated compelling evidence of a causal association between metabolites and the risk of breast cancer and its subtypes, underscoring the potential impact of metabolic interference on breast cancer risk and indicating the drug targets for breast cancer.
Collapse
Affiliation(s)
- Yilong Lin
- Department of Breast Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China
| | - Yue Zhang
- Department of Hematology, Xiangya Hospital, Xiangya School of Medicine, Central South University, Changsha, China
| | - Songsong Wang
- School of Medicine, Xiamen University, Xiamen, China
| | - Qingmo Yang
- Department of Breast Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
| |
Collapse
|
3
|
Zhang T, Fu S, Yu K, Albanes D, Moore SC, Purdue MP, Stolzenberg-Solomon RZ. Nested Case-Control Studies Investigating Serum Perfluorooctanoate and Perfluorooctane Sulfonate Levels and Pancreatic Ductal Adenocarcinoma in Two Cohorts. ENVIRONMENTAL HEALTH PERSPECTIVES 2023; 131:107702. [PMID: 37844029 PMCID: PMC10578516 DOI: 10.1289/ehp13208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/21/2023] [Revised: 08/15/2023] [Accepted: 09/29/2023] [Indexed: 10/18/2023]
Affiliation(s)
- Ting Zhang
- Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Rockville, Maryland, USA
| | - Sheng Fu
- Biostatistics Branch, DCEG, NCI, NIH, DHHS, Rockville, Maryland, USA
| | - Kai Yu
- Biostatistics Branch, DCEG, NCI, NIH, DHHS, Rockville, Maryland, USA
| | - Demetrius Albanes
- Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Rockville, Maryland, USA
| | - Steven C. Moore
- Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Rockville, Maryland, USA
| | - Mark P. Purdue
- Occupational and Environmental Epidemiology Branch, DCEG, NCI, NIH, DHHS, Rockville, Maryland, USA
| | - Rachael Z. Stolzenberg-Solomon
- Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Rockville, Maryland, USA
| |
Collapse
|